Concerning fecal transplantation in diabetes, as described in Ye et al.’s review of 2022, through studies in animal models, it has been shown that FMT early in life can significantly delay the development of DM1 in both MyD88-deficient mice and NOD mice receiving FMT with non-selective human microbiota. Here, MYD88 is linked to diabetes mellitus.